Clinical Trial

Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study

Study acronym: RECEPT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 9, 2025 (before its estimated January 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This prospective, multicenter observational study aims to evaluate the incidence, timing, and characteristics of residual and recurrent (restenosis) carotid artery stenosis following carotid endarterectomy (CEA) with primary closure. Conducted across several neurosurgical centers in the Czech Republic, the study will include patients undergoing elective CEA who meet standard clinical indications. Participants will undergo preoperative CT angiography and follow-up imaging at 30 days and 1 year post-surgery. Residual stenosis is defined as ≥50% luminal narrowing detected within 30 days postoperatively, while restenosis is evaluated at later time points. The study will also assess clinical outcomes such as ischemic stroke, TIA, myocardial infarction, and mortality. The standardized surgical technique and harmonized diagnostic algorithm across all centers aim to provide robust data on the performance and durability of primary closure CEA.
Trial Details
NCT Number NCT07057297
Lead Sponsor Charles University, Czech Republic
Collaborators: The University Hospital Plzeň, Masaryk Hospital Usti nad Labem, University Hospital Olomouc, County Hospital Liberec, Liberec, Czech Republic
Conditions Carotid Arteriosclerosis, Carotid Stenosis, Brain Stroke
Enrollment 300 participants
Start Date 2025-02-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-07-09